Highlights the increased risk of sudden cardiac death and QTc prolongation in patients with schizophrenia, emphasizing the need for cardiac risk assessment when prescribing antipsychotics.
No takes yet. Share an insight, caveat, or question.
Cardiac monitoring may be considered in schizophrenia; leaves open the causal contribution of antipsychotics and QTc prolongation.
Jindal et al. (2005) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: